The NHS says the benefits of hormone replacement therapy (HRT) usually outweigh the risks, and that both depend on your age, your menopause symptoms and any risk factors you have1. This guide is a summary of guidance published by the NHS, NICE and The Menopause Society. It is not advice. The balance for you is a conversation with your doctor or GP.
What are the benefits of HRT?
- NHS: «The main benefit of HRT is that it's effective at relieving most perimenopause and menopause symptoms». It names hot flashes (hot flushes), night sweats, sleep problems, anxiety and low mood, and vaginal dryness. It also says HRT helps to prevent osteoporosis1.
- NICE, the guideline body for England, tells clinicians to offer HRT to people with vasomotor symptoms (hot flashes and sweats) associated with menopause. It says fragility fracture risk is decreased while taking HRT2.
- The Menopause Society, in the US, says hormone therapy «remains the most effective treatment for vasomotor symptoms (VMS) and the genitourinary syndrome of menopause and has been shown to prevent bone loss and fracture»4.
NICE's discussion aid gives numbers, with fragility fractures as its marker of osteoporosis3.
| NICE discussion aid: fragility fractures | Women who never take HRT, out of 1,000 | Women who take HRT, out of 1,000 | Difference, as NICE states it |
|---|---|---|---|
| Ages 50 to 54 (over 5 years) | 60 | HRT for 5 years from the age of 50: 40 | 20 fewer women |
| Ages 50 to 59 (over 10 years) | 127 | HRT for 10 years from the age of 50: 80 | 47 fewer women |
If you have not begun yet, see starting HRT.
What are the risks of HRT?
The NHS says: «The risks of any serious side effects are usually very low, and depend on the type of HRT you take, how long you take it and your own health risks»1. The Menopause Society says the risks differ depending on type, dose, duration of use, route of administration, timing of initiation, and whether a progestogen is used4.
Combined HRT contains estrogen (oestrogen) and progestogen. NICE tells clinicians to offer it to people with a uterus, and estrogen-only HRT to people who have had a total hysterectomy2. Estrogen can be taken by mouth, or through the skin (transdermal) as a patch, gel or spray2. See types of HRT explained and HRT side effects.
NICE's figures are estimates of absolute risk. The discussion aid says they are «at a population rather than an individual level», calculated «using data on people starting HRT at age 50, as an example»3.
HRT and breast cancer
The NHS says: «HRT can slightly increase the risk of breast cancer». It says the risk increases the longer you take it and the older you are, and falls again after you stop. Of estrogen-only HRT it says there is «little or no increase in the risk of breast cancer». It gives one figure: «there are around 5 extra cases of breast cancer in every 1,000 women who take combined HRT for 5 years»1. The sentence names no age group and no counting period.
NICE says breast cancer risk increases with combined HRT. The increase rises with duration of use, and declines after stopping HRT «but persists at least 10 years after stopping use». For estrogen-only HRT it says there is «very little or no increase»2. Its figures count new cases across 20 years:
| NICE discussion aid: breast cancer, ages 50 to 69 (over 20 years) | Women who develop breast cancer, out of 1,000 | Difference, as NICE states it |
|---|---|---|
| Women who never take HRT | 59 | (comparison group) |
| Combined HRT for 5 years from the age of 50 | 79 | 20 more women |
| Combined HRT for 10 years from the age of 50 | 92 | 33 more women |
| Estrogen-only HRT for 5 years from the age of 50 | 69 | 10 more women |
| Estrogen-only HRT for 10 years from the age of 50 | 71 | 12 more women |
The NHS gives a single figure for 5 years of combined HRT. NICE counts cases over 20 years, by type of HRT and years of use1,3. The two counts use different measures, so this guide shows both.
Blood clots and stroke: tablets and skin forms
- NHS: «HRT tablets can increase the risk of blood clots, but the risk is still very low». «HRT patches, sprays and gels do not increase the risk of blood clots». On stroke: «HRT tablets (but not patches, gel or spray) slightly increase the risk of stroke. But the risk is still very low, particularly if you're under 60 years old»1.
- NICE: the risk of venous thromboembolism (VTE) is not increased with transdermal HRT and is increased with oral HRT. Stroke risk «is unlikely to increase» with transdermal estrogen, and increases with HRT that contains oral estrogen2. The discussion aid has no section on blood clots3.
- The Menopause Society: the risk of blood clots increases if you take hormones by mouth, and «may be lower» with a transdermal estrogen. Its patient page says both estrogen-only and combined therapy increase the risk of stroke5.
On stroke and skin forms the wording differs: the NHS says tablets increase the risk «but not patches, gel or spray», and NICE says the risk «is unlikely to increase».
Womb cancer, ovarian cancer, heart disease and dementia
The NHS page does not cover womb or ovarian cancer. It says taking HRT has «little or no effect on the risk of getting coronary heart disease» and that «it's not known whether HRT reduces the risk of dementia»1. NICE says:
- in people with a uterus, the risk of endometrial cancer (The Menopause Society also calls it uterine cancer) increases with estrogen-only HRT, decreases with continuous combined HRT, and may slightly increase with sequential combined HRT2,5
- in people with ovaries, there is «a very slight increase in ovarian cancer risk with combined HRT»2
- coronary heart disease risk does not increase with combined or estrogen-only HRT, and clinicians should not offer HRT to prevent cardiovascular disease or dementia2
- dementia risk «might increase with combined HRT if it is started at 65 or over»2
The Menopause Society's patient page differs on the heart: «If you start HT within 10 years of menopause, you could lower your risk of cardiovascular disease»5.
| NICE discussion aid: condition and period | Women who never take HRT, out of 1,000 | Women who take HRT, out of 1,000 | Difference, as NICE states it |
|---|---|---|---|
| Endometrial cancer, ages 50 to 54 (over 5 years) | 4 | Continuous combined HRT for an unknown duration from the age of 50: 1 | 3 fewer women |
| Endometrial cancer, same ages | 4 | Sequential combined HRT from the age of 50 for an unknown duration: 8 | 4 more women |
| Endometrial cancer, same ages, women with a uterus | 4 | Estrogen-only HRT from the age of 50 for an unknown duration: 11 | 7 more women |
| Ovarian cancer, ages 50 to 54 (over 5 years) | 1 | Combined or estrogen-only HRT for an unknown duration from the age of 50: 2 | 1 more woman |
| Stroke, ages 50 to 54 (over 5 years) | 3 | Oral estrogen-only HRT from the age of 50 for an unknown duration: 4 | 1 more woman |
| Dementia, over a 4-year period starting at age 65 or over | 9 | Combined HRT for 4 years, starting at age 65 or over: 18 | 9 more women |
On dementia, NICE adds that most women start HRT before 65, in their 50s, «but data for that age group was inconclusive»3.
How do age and time since menopause change the balance?
The NHS says: «If you're under 60 years old, have menopause symptoms, and are not at high risk of breast cancer or blood clots, the benefits of HRT are likely to outweigh the risks»1.
The Menopause Society says the benefit-risk ratio is favorable for women aged younger than 60 years, or within 10 years of menopause onset, who have no contraindications, for treating bothersome hot flashes and night sweats and preventing bone loss. For women who start more than 10 years from menopause onset, or aged older than 60 years, it «appears less favorable because of the greater absolute risks of coronary heart disease, stroke, venous thromboembolism, and dementia»4.
See also how long can you stay on HRT?
Who may not be able to take HRT?
The NHS says HRT may not be suitable if you have a history of breast cancer, ovarian cancer or womb cancer, have a history of blood clots, have untreated high blood pressure, have liver disease, or are pregnant. It says alternatives to HRT may be recommended instead6. See hot flashes without HRT.
What each source says about the decision
- NHS: «Talk to a GP, who will help you decide»1.
- NICE, to clinicians: «Tailor the information about benefits and risks to the person's age, individual circumstances and potential risk factors»2.
- The Menopause Society: «Treatment should be individualized using the best available evidence to maximize benefits and minimize risks, with periodic reevaluation of the benefits and risks of continuing therapy»4.
NICE also tells clinicians to rediscuss the benefits and risks of continuing at every review2. See your HRT review and your menopause appointment.
A dated record of your symptoms gives you something to read from in that conversation. Our menopause symptom diary is a free 4-week printable. Meno, our iPhone journal, puts your daily hot flash counts and symptoms on a one-page PDF for the appointment.
Common questions
Is HRT safe?
The NHS: «The benefits of hormone replacement therapy (HRT) usually outweigh the risks. Recent evidence says that the risks of serious side effects from HRT are very low»1.
Does HRT affect life expectancy?
NICE tells clinicians to explain that «overall, taking either combined HRT or oestrogen-only HRT is unlikely to affect life expectancy»2.
Is vaginal estrogen different?
The NHS: «Vaginal oestrogen helps with vaginal dryness. It does not increase the risk of breast cancer, blood clots or other conditions»1.
Sources
- NHS — Benefits and risks of hormone replacement therapy (HRT), page last reviewed 8 February 2023.
- NICE — Menopause: identification and management (NG23), Recommendations, published 12 November 2015, last updated 15 April 2026.
- NICE — HRT and the likelihood of some medical conditions: a discussion aid for healthcare professionals and patients (NG23), © NICE 2024.
- The North American Menopause Society — The 2022 hormone therapy position statement of The North American Menopause Society, Menopause, 2022 Jul 1;29(7):767-794 (PubMed abstract).
- The Menopause Society — Menopause Topics: Hormone Therapy, no date shown on the page.
- NHS — About hormone replacement therapy (HRT), page last reviewed 7 February 2023.
